Pages that link to "Q44967713"
Jump to navigation
Jump to search
The following pages link to Trial watch: Phase II failures: 2008-2010. (Q44967713):
Displaying 50 items.
- Unlocking proteomic heterogeneity in complex diseases through visual analytics (Q23921986) (← links)
- Estrogen receptor alpha gene amplification in breast cancer: 25 years of debate (Q24273274) (← links)
- Reproducible Research Practices and Transparency across the Biomedical Literature (Q24288789) (← links)
- A combined pre-clinical meta-analysis and randomized confirmatory trial approach to improve data validity for therapeutic target validation (Q24289291) (← links)
- Stable isotope-resolved metabolomics and applications for drug development (Q24629149) (← links)
- Excessive intimal hyperplasia in human coronary arteries before intimal lipid depositions is the initiation of coronary atherosclerosis and constitutes a therapeutic target (Q26748661) (← links)
- Is There a Space-Based Technology Solution to Problems with Preclinical Drug Toxicity Testing? (Q26749381) (← links)
- Drug discovery in ophthalmology: past success, present challenges, and future opportunities (Q26771638) (← links)
- Quality of Animal Experiments in Anti-Angiogenic Cancer Drug Development--A Systematic Review (Q26784003) (← links)
- Predictive biomarkers in precision medicine and drug development against lung cancer (Q26824536) (← links)
- Advancing Biological Understanding and Therapeutics Discovery with Small-Molecule Probes (Q26829985) (← links)
- Murine models of inflammatory bowel disease (IBD): challenges of modeling human disease (Q26863622) (← links)
- Pharmacotherapy of amphetamine-type stimulant dependence: an update (Q26991936) (← links)
- Linked clinical trials--the development of new clinical learning studies in Parkinson's disease using screening of multiple prospective new treatments (Q26995786) (← links)
- Gaddum Memorial Lecture 2014: receptors as an evolving concept: from switches to biased microprocessors (Q27005640) (← links)
- Improving and accelerating drug development for nervous system disorders (Q27008349) (← links)
- Proceedings of the 2013 CINP summit: innovative partnerships to accelerate CNS drug discovery for improved patient care (Q27013891) (← links)
- Review: basics of drug development in rheumatology (Q28083593) (← links)
- A mechanistic, model-based approach to safety assessment in clinical development (Q28395802) (← links)
- Risk in vaccine research and development quantified (Q28488506) (← links)
- Human Organotypic Lung Tumor Models: Suitable For Preclinical 18F-FDG PET-Imaging (Q28553420) (← links)
- Authorization of Animal Experiments Is Based on Confidence Rather than Evidence of Scientific Rigor (Q28590246) (← links)
- Look back in anger - what clinical studies tell us about preclinical work (Q28677000) (← links)
- Stock market returns and clinical trial results of investigational compounds: an event study analysis of large biopharmaceutical companies (Q28686746) (← links)
- Believe it or not: how much can we rely on published data on potential drug targets? (Q29547529) (← links)
- Portfolio Decisions in Early Development (Q29999056) (← links)
- Tractable synthesis of multipurpose screening compounds with under-represented molecular features for an open access screening platform (Q30486847) (← links)
- Substituted tetrazoles as multipurpose screening compounds. (Q30490583) (← links)
- A microRNA miR-34a-regulated bimodal switch targets Notch in colon cancer stem cells. (Q30539598) (← links)
- A model-based approach to predict longitudinal HbA1c, using early phase glucose data from type 2 diabetes mellitus patients after anti-diabetic treatment. (Q30619387) (← links)
- Pharmacogenomics of neuropsychiatric disorders: analysis of genetic variability in 162 identified neuroreceptors using 1000 Genomes Project data (Q30863802) (← links)
- Pharmacogenomic and clinical data link non-pharmacokinetic metabolic dysregulation to drug side effect pathogenesis (Q30968128) (← links)
- Towards using a full spectrum of early clinical trial data: a retrospective analysis to compare potential longitudinal categorical models for molecular targeted therapies in oncology. (Q30968729) (← links)
- Can animal data translate to innovations necessary for a new era of patient-centred and individualised healthcare? Bias in preclinical animal research (Q30983045) (← links)
- Key role of publication of clinical data for target validation (Q30984622) (← links)
- Addressing potential prior-data conflict when using informative priors in proof-of-concept studies (Q31036717) (← links)
- Exploiting Pharmacological Similarity to Identify Safety Concerns - Listen to What the Data Tells You. (Q31118982) (← links)
- Animal models of hospital-acquired pneumonia: current practices and future perspectives (Q33575296) (← links)
- Molecular deconstruction, detection, and computational prediction of microenvironment-modulated cellular responses to cancer therapeutics (Q33605227) (← links)
- The golden retriever model of Duchenne muscular dystrophy (Q33709114) (← links)
- From computational modelling of the intrinsic apoptosis pathway to a systems-based analysis of chemotherapy resistance: achievements, perspectives and challenges in systems medicine. (Q33720383) (← links)
- Bringing together the academic drug discovery community (Q33824937) (← links)
- Pharmacologic management of Duchenne muscular dystrophy: target identification and preclinical trials (Q34152280) (← links)
- The future of molecular dynamics simulations in drug discovery (Q34241696) (← links)
- Data mining reveals a network of early-response genes as a consensus signature of drug-induced in vitro and in vivo toxicity (Q34384283) (← links)
- Gene mutations in primary tumors and corresponding patient-derived xenografts derived from non-small cell lung cancer (Q34994030) (← links)
- Small molecule screening in human induced pluripotent stem cell-derived terminal cell types (Q35074117) (← links)
- Challenges and opportunities toward enabling phenotypic screening of complex and 3D cell models (Q35602409) (← links)
- Use of Baculovirus BacMam Vectors for Expression of ABC Drug Transporters in Mammalian Cells (Q35688446) (← links)
- Use of Humanized Mice to Study the Pathogenesis of Autoimmune and Inflammatory Diseases (Q35738486) (← links)